Hodgkin Lymphoma (HL) among children and adolescents/young adults (AYAs; 15-39 years) represents a highly treatable malignancy. While the estimated 5-year survival exceeds 95% in most patients, ...
Under the auspices of the Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) consortium, a phase 1-2 clinical trial led by UC San Francisco pediatric oncologist Elliot Stieglitz, MD, will ...
I don’t have children of my own, so it’s hard to imagine how a parent responds to those words. But 28 years ago, my parents found themselves facing that dilemma. It’s strange to look back on a moment ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, and Blood ...
HOUSTON, Texas (KTRK) -- A blood cancer diagnosis can bring dark moments not just for patients, but everyone who loves them. This fall, you can help illuminate a path through Houston and Montgomery ...
Extraosseous Localized Ewing Tumors: Improved Outcome With Anthracyclines—The French Society of Pediatric Oncology and International Society of Pediatric Oncology We evaluated the long-term effects of ...
For every possible cause of childhood leukemia pain, your child’s team of doctors and healthcare providers has a way to manage it. This year, about 15,000 parents will learn that their child or teen ...
Please enable JavaScript to read this content. Daniel Mbugua in hospital in India. Mbugua has been in the country since December receiving treatment not Non Hodgkin's ...
The Haveras are teaming up to raise money for the Leukemia and Lymphoma Society's annual Light the Night walk. The Haveras are teaming up to raise money for the Leukemia and Lymphoma Society's annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results